{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:09:06Z","timestamp":1787990946145,"version":"build-2784847793"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jmii.2023.01.013","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T21:33:54Z","timestamp":1675287234000},"page":"598-604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Microbiological and clinical characteristics of Streptococcus pneumoniae serotype 3 infection and risk factors for severe outcome: A multicenter observational study"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7174-5470","authenticated-orcid":false,"given":"Merve Arslan","family":"Aydin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4331-0925","authenticated-orcid":false,"given":"Rajendra Prasad","family":"Janapatla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4591-0924","authenticated-orcid":false,"given":"Chyi-Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Chieh","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Hui","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4324-7743","authenticated-orcid":false,"given":"Cheng-Hsun","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2023.01.013_bib1","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001446","article-title":"JMM Profile: Streptococcus pneumoniae: sugar-coated captain of the men of death","volume":"70","author":"Dao","year":"2021","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jmii.2023.01.013_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.613287","article-title":"Sugar-coated killer: serotype 3 pneumococcal disease","volume":"10","author":"Luck","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jmii.2023.01.013_bib3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/genes10110845","article-title":"Evolution of Streptococcus pneumoniae serotype 3 in England and Wales: a major vaccine evader","volume":"10","author":"Groves","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jmii.2023.01.013_bib4","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jgar.2021.07.005","volume":"26","author":"Chien","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jmii.2023.01.013_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039150","article-title":"Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes","volume":"7","author":"van Hoek","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2023.01.013_bib6","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine against medically-attended lower respiratory tract infection and pneumonia among older adults","author":"Lewnard","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2023.01.013_bib7","series-title":"Performance standards for antimicrobial susceptibility testing","isbn-type":"print","year":"2022","ISBN":"https:\/\/id.crossref.org\/isbn\/9781684401352"},{"key":"10.1016\/j.jmii.2023.01.013_bib8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3346\/jkms.2011.26.8.971","article-title":"Streptococcus pneumoniae type determination by multiplex polymerase chain reaction","volume":"26","author":"Yun","year":"2011","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jmii.2023.01.013_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00978-2021","article-title":"Serotype transmission dynamics and reduced incidence of invasive pneumococcal disease caused by different serotypes after implementation of non-pharmaceutical interventions during COVID-19 pandemic","volume":"58","author":"Janapatla","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jmii.2023.01.013_bib10","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1016\/j.vaccine.2019.05.003","article-title":"Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: a study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN)","volume":"37","author":"LeBlanc","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jmii.2023.01.013_bib11","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/microorganisms9071428","article-title":"Portuguese Group for the Study of Streptococcal Infections, et\u00a0al. Pediatric invasive pneumococcal disease three years after PCV13 introduction in the national immunization plan\u2014the continued importance of serotype 3","volume":"9","author":"Silva-Costa","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.jmii.2023.01.013_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2016.e00198","article-title":"The incidence of invasive pneumococcal serotype 3 disease in the Danish population is not reduced by PCV-13 vaccination","volume":"2","author":"Slotved","year":"2016","journal-title":"Heliyon"},{"key":"10.1016\/j.jmii.2023.01.013_bib13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/1471-2334-13-492","article-title":"High incidence of septic shock caused by Streptococcus pneumoniae serotype 3A retrospective epidemiological study","volume":"13","author":"Ahl","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2023.01.013_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1099\/jmm.0.028803-0","article-title":"Death or survival from invasive pneumococcal disease in Scotland: associations with serogroups and multilocus sequence types","volume":"60","author":"Inverarity","year":"2011","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jmii.2023.01.013_bib15","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.vaccine.2019.10.056","article-title":"Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion\/empyema after the introduction of PCV13 in Germany","volume":"38","author":"Goettler","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jmii.2023.01.013_bib16","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1093\/cid\/ciaa1427","article-title":"Major adverse cardiovascular events during invasive pneumococcal disease are serotype dependent","volume":"72","author":"Africano","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2023.01.013_bib17","doi-asserted-by":"crossref","first-page":"123\u20129","DOI":"10.1016\/j.pulmoe.2019.10.003","article-title":"Pneumonia mortality, comorbidities matter?","volume":"26","author":"Hespanhol","year":"2020","journal-title":"Pulmonology"},{"key":"10.1016\/j.jmii.2023.01.013_bib18","doi-asserted-by":"crossref","first-page":"840\u20127","DOI":"10.1086\/315760","article-title":"Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries","volume":"182","author":"Kalin","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2023.01.013_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007438","article-title":"Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci","volume":"14","author":"Azarian","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jmii.2023.01.013_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.648040","article-title":"Properties of mucoid serotype 3 Streptococcus pneumoniae from children in China","volume":"11","author":"Yang","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jmii.2023.01.013_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/INF.0b013e31816fca86","article-title":"An international serotype 3 clone causing pediatric noninvasive infections in Israel, Costa Rica, and Lithuania","volume":"27","author":"Porat","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jmii.2023.01.013_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-016-2353-3","article-title":"Invasive pneumococcal disease caused by mucoid serotype 3 Streptococcus pneumoniae: a case report and literature review","volume":"10","author":"Sugimoto","year":"2017","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jmii.2023.01.013_bib23","doi-asserted-by":"crossref","first-page":"e00478","DOI":"10.1128\/AAC.00478-17","article-title":"Genome evolution to penicillin resistance in serotype 3 Streptococcus pneumoniae by capsular switching","volume":"61","author":"Chiba","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2023.01.013_bib24","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3201\/eid2706.203629","article-title":"Serotype-switch variant of multidrug-resistant Streptococcus pneumoniae sequence type 271","volume":"27","author":"Scherer","year":"2021","journal-title":"Emerg Infect Dis"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118223000130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118223000130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:29:00Z","timestamp":1761658140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118223000130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1684118223000130"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2023.01.013","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiological and clinical characteristics of Streptococcus pneumoniae serotype 3 infection and risk factors for severe outcome: A multicenter observational study","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2023.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}